Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,537,724
-$255,436 QoQ
Shares Held
63,859
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#1,083
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Knuff & Co LLC holds $24,047,308 across 10 Drug Manufacturers - General names. PFE ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
242,776 | $11,638,681 | |
| 2 | JNJ |
Johnson & Johnson
|
10,973 | $2,786,812 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
17,641 | $2,228,763 | |
| 4 | ABBV |
AbbVie Inc.
|
8,555 | $2,152,780 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,038 | $1,675,383 | |
| 6 | PFE |
Pfizer Inc
This page
|
63,859 | $1,537,724 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,438 | $947,157 | |
| 8 | AMGN |
Amgen Inc
|
1,800 | $651,816 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,537,724 | 63,859 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,793,160 | 63,859 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,590,089 | 63,859 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,627,127 | 63,859 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,549,663 | 63,930 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,618,187 | 63,859 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,712,723 | 64,558 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,868,308 | 64,558 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,811,956 | 64,759 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,819,262 | 65,559 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,887,443 | 65,559 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,195,820 | 66,199 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,562,684 | 69,866 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,729,071 | 66,889 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $3,439,843 | 67,132 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,939,665 | 67,177 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $3,522,090 | 67,177 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,478,788 | 67,197 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,865,908 | 99,338 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $4,299,408 | 99,963 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,914,551 | 99,963 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,622,565 | 99,988 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $3,680,558 | 99,988 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $3,758,736 | 102,418 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,255,549 | 99,558 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $3,164,704 | 96,958 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||